Transport characteristics of the slow therapies: implications for achieving adequacy of dialysis in acute renal failure
- PMID: 8996622
- DOI: 10.1016/s1073-4449(97)70018-9
Transport characteristics of the slow therapies: implications for achieving adequacy of dialysis in acute renal failure
Abstract
Slow continuous renal replacement therapy is used primarily to treat critically ill patients with acute renal failure. Knowledge of the small solute transport characteristics in continuous renal replacement therapy (CRRT) provides a rational basis for the manipulation of operating conditions to achieve desired clearances and, hence, desired metabolic control. These manipulations simply involve varying the dialysate inflow rate, the ultrafiltration rate, and the substitution fluid replacement rate. For the diffusion-based therapies, the condition of dialysate saturation, ie, exiting dialysis fluid urea nitrogen (FUN) approximating inflowing plasma water urea nitrogen (BUN, ie, the FUN/BUN ratio approximately 1), simplifies these manipulations. Examples of the calculations required to compute urea generation rate, protein catabolic rate, and the desired clearances are given. However, all of these calculations leave unanswered the question of "what is adequate dialysis" in the critically ill patient with acute renal failure. In the absence of the data that are required to answer this question, one can only say that if dialysis makes a difference, the persistently high mortality rate in intensive care unit acute renal failure suggests that patients are not receiving enough Kt/V. The reasons why CRRT is inherently more efficient than intermittant hemodialysis are explored. The usual reasons why prescribed therapy is less than delivered therapy with respect to slow continuous therapy are also discussed.
Similar articles
-
Extracorporeal therapy requirements for patients with acute renal failure.J Am Soc Nephrol. 1997 May;8(5):804-12. doi: 10.1681/ASN.V85804. J Am Soc Nephrol. 1997. PMID: 9176851
-
Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy.Am J Kidney Dis. 2002 Mar;39(3):556-70. doi: 10.1053/ajkd.2002.31406. Am J Kidney Dis. 2002. PMID: 11877575
-
[The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].Zhonghua Nei Ke Za Zhi. 2001 Mar;40(3):183-6. Zhonghua Nei Ke Za Zhi. 2001. PMID: 11798577 Chinese.
-
What dialysis dose should be provided in acute renal failure? A review.Adv Ren Replace Ther. 1995 Jul;2(3):255-64. doi: 10.1016/s1073-4449(12)80059-8. Adv Ren Replace Ther. 1995. PMID: 7614362 Review.
-
Dialysis adequacy in patients with acute renal failure.Curr Opin Nephrol Hypertens. 1999 Nov;8(6):695-700. doi: 10.1097/00041552-199911000-00008. Curr Opin Nephrol Hypertens. 1999. PMID: 10630815 Review.
Cited by
-
Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.Antimicrob Agents Chemother. 2000 Jun;44(6):1639-44. doi: 10.1128/AAC.44.6.1639-1644.2000. Antimicrob Agents Chemother. 2000. PMID: 10817721 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources